Tamsulosin

Generic Name
Tamsulosin
Brand Names
Flomax, Jalyn
Drug Type
Small Molecule
Chemical Formula
C20H28N2O5S
CAS Number
106133-20-4
Unique Ingredient Identifier
G3P28OML5I
Background

Tamsulosin is a selective alpha-1A and alpha-1B adrenoceptor antagonist that exerts its greatest effect in the prostate and bladder, where these receptors are most common. It is indicated for the treatment of signs and symptoms of benign prostatic hypertrophy. Antagonism of these receptors leads to relaxation of smooth muscle in the prostate and detrusor mus...

Indication

Tamsulosin is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia.

Tamsulosin is also used off label for the treatment of ureteral stones, prostatitis, and female voiding dysfunction.

Associated Conditions
Benign Prostatic Hyperplasia (BPH), Benign Prostatic Hypertrophy, Bladder Outlet Obstruction, Ureteral Calculus
Associated Therapies
-

Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)

First Posted Date
2019-09-27
Last Posted Date
2019-09-27
Lead Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Target Recruit Count
141
Registration Number
NCT04107896
Locations
🇧🇩

Maidul islam, Dhaka, Bangladesh

Prophylactic Administration of Alpha Blockers for Prevention of Urinary Retention in Males Undergoing Inguinal Hernia Repair Under Spinal Anaesthesia.

First Posted Date
2019-06-06
Last Posted Date
2021-11-26
Lead Sponsor
Georgios Koukoulis
Target Recruit Count
100
Registration Number
NCT03976934
Locations
🇬🇷

General Hospital Of Larissa, Larissa, Greece

🇬🇷

University General Hospital of Larissa, Larissa, Greece

Effect of Tamsulosin on PE Compared With Paroxetine Hydrochloride

First Posted Date
2019-03-19
Last Posted Date
2019-03-19
Lead Sponsor
Assiut University
Target Recruit Count
160
Registration Number
NCT03879746

Prevention of Postoperative Urinary Retention with Treatment of Tamsulosin 5 Days Prior to Lower Limb Arthroplasty

First Posted Date
2019-01-17
Last Posted Date
2024-10-24
Lead Sponsor
Kantonsspital Graubünden
Target Recruit Count
170
Registration Number
NCT03808155
Locations
🇨🇭

Kantonsspital Graubünden, Chur, Graubünden, Switzerland

Use of Hyoscyamine Versus Tamsulosin for Management of Ureteral Stent Irritation

First Posted Date
2018-11-23
Last Posted Date
2024-12-03
Lead Sponsor
University of Kansas Medical Center
Target Recruit Count
5
Registration Number
NCT03750656
Locations
🇺🇸

University of Kansas Medical Center, Kansas City, Kansas, United States

Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:

First Posted Date
2018-10-17
Last Posted Date
2023-10-12
Lead Sponsor
Mansoura University
Target Recruit Count
200
Registration Number
NCT03709992
Locations
🇪🇬

Ahmed R EL-Nahas, Mansoura, Kuwait, Egypt

Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery

First Posted Date
2018-05-14
Last Posted Date
2021-11-08
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
132
Registration Number
NCT03524339
Locations
🇺🇸

University Hospitals, Cleveland, Ohio, United States

🇺🇸

University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

Prophylactic Alpha-blockers in the Prevention of Urinary Retention Post Inguinal Hernia Repair

First Posted Date
2017-10-19
Last Posted Date
2017-10-19
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
300
Registration Number
NCT03314259

Hernia Surgery Urinary Retention

Phase 4
Conditions
Interventions
First Posted Date
2017-01-20
Last Posted Date
2018-03-23
Lead Sponsor
Memorial Health University Medical Center
Target Recruit Count
140
Registration Number
NCT03027115
Locations
🇺🇸

Memorial Health University Medical Center, Savannah, Georgia, United States

Preoperative Administration of Tamsulosin for Prevention of Post Operative Urinary Retention in Males Undergoing Elective Inguinal Hernia Repair

First Posted Date
2016-11-08
Last Posted Date
2019-07-30
Lead Sponsor
Ascension Health
Target Recruit Count
210
Registration Number
NCT02958878
© Copyright 2024. All Rights Reserved by MedPath